1-amino-1,3-dicarboxycyclopentane has been researched along with phosphatidylethanol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moroni, F; Pellegrini-Giampietro, DE; Torregrossa, SA | 1 |
Costantino, G; Marinozzi, M; Moroni, F; Natalini, B; Pellegrini-Giampietro, D; Pellicciari, R | 1 |
2 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and phosphatidylethanol
Article | Year |
---|---|
Pharmacological characterization of metabotropic glutamate receptors coupled to phospholipase D in the rat hippocampus.
Topics: Analysis of Variance; Animals; Brain; Cycloleucine; Enzyme Induction; Glycerophospholipids; Hippocampus; Male; Phosphatidic Acids; Phosphatidylcholines; Phospholipase D; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Signal Transduction; Stereoisomerism | 1996 |
(2R,1'S,2'R,3'S)-2-(2'-Carboxy-3'-phenylcyclopropyl)glycine (PCCG-13), the first potent and selective competitive antagonist of phospholipase D-coupled metabotropic glutamate receptors: asymmetric synthesis and preliminary biological properties.
Topics: Animals; Cycloleucine; Cyclopropanes; Glycerophospholipids; Glycine; Hippocampus; In Vitro Techniques; Phospholipase D; Rats; Receptors, Metabotropic Glutamate; Stereoisomerism; Type C Phospholipases | 1999 |